Tower Research Capital LLC (Trc) Innoviva, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Innoviva, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,230 shares of INVA stock, worth $49,617. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,230
Previous 6,907
67.71%
Holding current value
$49,617
Previous $138,000
71.01%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding INVA
# of Institutions
281Shares Held
82.7MCall Options Held
13.2KPut Options Held
156K-
Black Rock Inc. New York, NY9.63MShares$214 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.1MShares$158 Million0.0% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$140 Million0.14% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.59MShares$102 Million0.12% of portfolio
-
Dimensional Fund Advisors LP Austin, TX4.33MShares$96.4 Million0.02% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.55B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...